BSECompany Update4 Aug 2026 · 4 Aug 2026, 01:13 pm
Investor Conference
Zydus Lifesciences Ltd · 532321
✦ AI Summary
Zydus Lifesciences Ltd will participate in the Emkay Confluence 2026 investor conference on August 13, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
eac29ac4-e483-4c5c-8047-0b987fab8006.pdf
View document text
August 4, 2026
Listing Department Code: 532321
BSE LIMITED
P J Towers, Dalal Street,
Mumbai-400 001
Listing Department Code: Zyduslife
NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Exchange Plaza, C/1, Block G,
Bandra-Kurla Complex,
Bandra (E),
Mumbai-400 051
Re.: Investor Conference
This is to inform that the Company is going to participate in an investor conference viz. Emkay
Confluence 2026 on August 13, 2026.
Please bring the aforesaid update to the notice of the members of the exchange and the
investors’ at large.
Thanking you,
Yours faithfully,
For, ZYDUS LIFESCIENCES LIMITED
DHAVAL N. SONI
COMPANY SECRETARY AND COMPLIANCE OFFICER
MEMBERSHIP NO. FCS7063